Investors Shareholders

About
Teams
Sustainability
Investments
Media

Current portfolio

DNA Script

Young Paris based company pioneering enzymatic DNA synthesis

Sector
Healthcare
Country
France
Fund
LSP 6
Entry
2019
Web
dnascript.com

Sector
Healthcare
Country
France
Fund
LSP 6
Entry
2019
Web
dnascript.com

Latest news

27 November 2023
EQT AB’s Nomination Committee for the Annual Shareholders’ Meeting 2024
27 November 2023
BPEA EQT Mid-Market Growth to acquire a majority stake in HRBrain, a fast-growing HR software provider in Japan
10 November 2023
BPEA EQT to commence Tender Offer to privatize Benesse Holdings, Inc. in partnership with its founding family
08 November 2023
EQT and Nobel Prize Outreach – exploring the role of generative AI in finance
06 November 2023
EQT Infrastructure to acquire Statera, a leading battery storage and flexible generation platform supporting the UK’s renewable energy transition

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of news

Regulatory News

EQT News

Preferred languageEnglishSwedish

Email address

Offices

Europe
North America
- New York
- San Francisco
APAC

About

EQT Playbook
Fund investors
Purpose and Culture
EQT Foundation
- EQT Foundation
Careers
- Life at EQT
- EQT Academy
Motherbrain

Teams

Roles

Sustainability

Future-proofing

Business Segments

Private Capital
Real Assets

Investments

Portfolio

Shareholders

About EQT AB Group
IPO on Nasdaq Stockholm
Reports and Presentations
Corporate Governance
About the Share

Media

Newsroom
- News
- Reports and presentations

Contact

Media
- Press Contact
Follow

Legal

Sustainable Finance Disclosure
Complaints Handling Procedure
Glossary and Definitions
Policies
Cookie Policy
Terms and Conditions

About

Teams

Sustainability

Investments

Shareholders

Media

Contact

Legal

A purpose-driven global investment organization

© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180